IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    Report: Some air traffic controllers under influence of alcohol or drugs while working

    02:01
  • ‘It was just magical’: Ohio neighbors share Christmas tradition

    03:01
  • Polar bear sightings surge in small Canadian town due to lack of sea ice

    03:40
  • Suspect arrested in fatal shootings of 3 men experiencing homelessness, LAPD reports

    01:57
  • Trump and DeSantis both hold campaign events in Iowa on Saturday

    02:03
  • George Santos threatens to file ethics complaints against former colleagues

    01:50
  • Israel resumes bombardment of Gaza after collapse of fragile truce with Hamas

    02:58
  • NBC News visits children’s literacy program in Mississippi with Jennifer Garner

    03:40
  • College student shot in Burlington, Vermont speaks out

    01:43
  • Increase in pediatric pneumonia in Ohio as CDC reports uptick in respiratory viruses nationwide

    02:00
  • Sandra Day O’Connor, first female Supreme Court justice, dies at 93

    02:32
  • Fighting resumes in Gaza after cease-fire ends

    03:09
  • Son of hostage still in Gaza speaks out as fighting resumes

    01:49
  • George Santos expelled from Congress after House vote

    03:27
  • Henry Kissinger, consequential diplomat and former secretary of state, dies at 100

    02:28
  • Electric road in Detroit can wirelessly charge EVs as they drive

    01:37
  • 19 deaths involving alleged carbon monoxide poisoning at Airbnbs since 2013: NBC News investigation

    02:49
  • Murder of Hollywood social activist Michael Latt was targeted, authorities say

    01:45
  • Elon Musk speaks out amid backlash over X post

    01:49
  • House Republicans set to decide fate of Rep. George Santos tomorrow

    01:45

White House to develop antiviral Covid pills as delta variant spreads

01:29

The White House says it will spend $3.2 billion to develop new antiviral, over the counter pills to potentially treat Covid-19 and future viruses. The delta variant now accounts for 10 percent of all U.S. cases.